Panvista D 30 mg/40 mg Capsule
By Panvista D
Rx
10 Capsule in a Strip

Composition
Domperidone(30mg) + Pantoprazole(40mg)

Manufacturer - Elder Pharmaceuticals Ltd
"Elder House" Plot No. C-9, Dalia Industrial Estate, Off Veera Desai Road, Andheri (W), Mumbai – 400053.

Expires on or after
October, 2025

liver
Panvista D 30 mg/40 mg Capsule is considered safe for use in individuals with liver disease. Available data indicates that adjusting the dose of Panvista D 30 mg/40 mg Capsule may not be necessary for patients with liver issues. It is advisable to consult with your healthcare provider for personalized guidance on the use of this medication.

kidney
Panvista D 30 mg/40 mg Capsule requires caution in patients with kidney disease. Dosage adjustments may be necessary. Consult your doctor regarding kidney-related concerns.

alcohol
When taking Panvista D 30 mg/40 mg Capsule, be cautious when consuming alcohol. It is recommended to consult with your doctor regarding the use of alcohol.

driving
When taking Panvista D 30 mg/40 mg Capsule, it may reduce alertness, impact vision, or induce drowsiness and dizziness. Refrain from driving if experiencing these effects.

pregnancy
Panvista D 30 mg/40 mg Capsule may not be safe to use during pregnancy. Animal studies have shown harm to the developing baby. Your doctor will assess the benefits and risks before prescribing this medication. Please consult your doctor before using Panvista D 30 mg/40 mg Capsule.

breastfeeding
During breastfeeding, caution is advised when using Panvista D 30 mg/40 mg Capsule. It is recommended to delay breastfeeding until the mother has completed treatment and the drug is cleared from her system.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | GASTRO INTESTINAL |
Action Class | - |
₹29.93
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024